View in EDS

Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.

Saved in:
Bibliographic Details
Title: Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.
Authors: Rutherford SC; Weill Cornell Medicine, New York, NY., Li H; Fred Hutchinson Cancer Center, Seattle, WA., Herrera AF; City of Hope Comprehensive Cancer Center, Duarte, CA., LeBlanc M; Fred Hutchinson Cancer Center, Seattle, WA., Ahmed S; The University of Texas MD Anderson Cancer Center, Houston, TX., Davison K; Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada., Parsons SK; Tufts Medical Center, Boston, MA., Unger JM; Fred Hutchinson Cancer Center, Seattle, WA., Perry AM; University of Michigan, Ann Arbor, MI., Casulo C; Wilmot Cancer Center, University of Rochester, Rochester, NY., Bartlett NL; Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO., Tuscano JM; University of California, Davis Medical Center, Sacramento, CA., Hess BT; Medical University of South Carolina, Charleston, SC., Torka P; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Kumar P; Illinois CancerCare, Bloomington, IL., Jacobs R; Atrium Health Levine Cancer Institute, Charlotte, NC., Song JY; City of Hope Comprehensive Cancer Center, Duarte, CA., Castellino SM; Department of Pediatrics, Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Atlanta, GA., Kahl B; Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO., Leonard JP; Weill Cornell Medicine, New York, NY., Smith SM; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL., Friedberg JW; Wilmot Cancer Center, University of Rochester, Rochester, NY., Evens AM; Division of Blood Disorders, Rutgers Cancer Institute New Jersey, New Brunswick, NJ.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Sep 20; Vol. 43 (27), pp. 2968-2973. Date of Electronic Publication: 2025 Jun 16.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40523203
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rutherford+SC%22">Rutherford SC</searchLink>; Weill Cornell Medicine, New York, NY.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Fred Hutchinson Cancer Center, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Herrera+AF%22">Herrera AF</searchLink>; City of Hope Comprehensive Cancer Center, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22LeBlanc+M%22">LeBlanc M</searchLink>; Fred Hutchinson Cancer Center, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Ahmed+S%22">Ahmed S</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Davison+K%22">Davison K</searchLink>; Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Parsons+SK%22">Parsons SK</searchLink>; Tufts Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Unger+JM%22">Unger JM</searchLink>; Fred Hutchinson Cancer Center, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Perry+AM%22">Perry AM</searchLink>; University of Michigan, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Casulo+C%22">Casulo C</searchLink>; Wilmot Cancer Center, University of Rochester, Rochester, NY.<br /><searchLink fieldCode="AU" term="%22Bartlett+NL%22">Bartlett NL</searchLink>; Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO.<br /><searchLink fieldCode="AU" term="%22Tuscano+JM%22">Tuscano JM</searchLink>; University of California, Davis Medical Center, Sacramento, CA.<br /><searchLink fieldCode="AU" term="%22Hess+BT%22">Hess BT</searchLink>; Medical University of South Carolina, Charleston, SC.<br /><searchLink fieldCode="AU" term="%22Torka+P%22">Torka P</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Kumar+P%22">Kumar P</searchLink>; Illinois CancerCare, Bloomington, IL.<br /><searchLink fieldCode="AU" term="%22Jacobs+R%22">Jacobs R</searchLink>; Atrium Health Levine Cancer Institute, Charlotte, NC.<br /><searchLink fieldCode="AU" term="%22Song+JY%22">Song JY</searchLink>; City of Hope Comprehensive Cancer Center, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Castellino+SM%22">Castellino SM</searchLink>; Department of Pediatrics, Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Kahl+B%22">Kahl B</searchLink>; Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO.<br /><searchLink fieldCode="AU" term="%22Leonard+JP%22">Leonard JP</searchLink>; Weill Cornell Medicine, New York, NY.<br /><searchLink fieldCode="AU" term="%22Smith+SM%22">Smith SM</searchLink>; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Friedberg+JW%22">Friedberg JW</searchLink>; Wilmot Cancer Center, University of Rochester, Rochester, NY.<br /><searchLink fieldCode="AU" term="%22Evens+AM%22">Evens AM</searchLink>; Division of Blood Disorders, Rutgers Cancer Institute New Jersey, New Brunswick, NJ.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2025 Sep 20; Vol. 43 (27), pp. 2968-2973. <i>Date of Electronic Publication: </i>2025 Jun 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40523203
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO-25-00204
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2968
    Titles:
      – TitleFull: Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rutherford SC
      – PersonEntity:
          Name:
            NameFull: Li H
      – PersonEntity:
          Name:
            NameFull: Herrera AF
      – PersonEntity:
          Name:
            NameFull: LeBlanc M
      – PersonEntity:
          Name:
            NameFull: Ahmed S
      – PersonEntity:
          Name:
            NameFull: Davison K
      – PersonEntity:
          Name:
            NameFull: Parsons SK
      – PersonEntity:
          Name:
            NameFull: Unger JM
      – PersonEntity:
          Name:
            NameFull: Perry AM
      – PersonEntity:
          Name:
            NameFull: Casulo C
      – PersonEntity:
          Name:
            NameFull: Bartlett NL
      – PersonEntity:
          Name:
            NameFull: Tuscano JM
      – PersonEntity:
          Name:
            NameFull: Hess BT
      – PersonEntity:
          Name:
            NameFull: Torka P
      – PersonEntity:
          Name:
            NameFull: Kumar P
      – PersonEntity:
          Name:
            NameFull: Jacobs R
      – PersonEntity:
          Name:
            NameFull: Song JY
      – PersonEntity:
          Name:
            NameFull: Castellino SM
      – PersonEntity:
          Name:
            NameFull: Kahl B
      – PersonEntity:
          Name:
            NameFull: Leonard JP
      – PersonEntity:
          Name:
            NameFull: Smith SM
      – PersonEntity:
          Name:
            NameFull: Friedberg JW
      – PersonEntity:
          Name:
            NameFull: Evens AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 09
              Text: 2025 Sep 20
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 27
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1